Global Contraceptive Market is Expected to Grow at the CAGR of 4.3% During 2015-2022 And It Estimated To Be $32.9 billio

According to a recently published report, the Global Contraceptive Market is expected to grow at the CAGR of 4.3% during 2015-2022 and it estimated to be $32.9 billion by 2022. The global contraceptive market is segmented on the basis of products, and geography. The report on global contraceptive market forecast 2015-2022 provides detailed overview and predictive analysis of the market.
The global contraceptive market is expected to grow well during the forecasted period on the back of factors such as growing prevalence of sexually transmitted infections (STIs), such as HIV. The presence of high unmet contraceptive needs coupled with the implementation of favorable government policies is expected to significantly contribute towards the growth of the contraceptives industry. However various ethical and social issues restrict the use of contraceptives in some countries in Middle-East region. These are some factors restraining the market growth.
Full report available Gobal Contraceptive Market Forecast 2015-2022 report at http://www.briskinsights.com/report/contraceptive-market
The application market for contraceptive is segmented by products and geography. The products segment is further divided into drugs, such as topical contraceptives, injectable, and oral contraceptive pills. Out of all the segments, contraceptive devices holds the largest market share with 62%, presently. Male and female condoms, vaginal implants, subdermal implants, diaphragms, sponges and IUDs are key devices accounted for the significant share of the contraceptives market in terms of revenue. This is because of the increase in the awareness level about sexually transmitted disease (STD) and the efficiency of condoms to prevent the infections, including HIV.
The key players in global contraceptive market include Teva Pharmaceutical Industries, The Female Health Company, Reckitt Benckiser Plc, Pfizer Inc., Church & Dwight, Mayer Laboratories, Cooper Surgical, Actavis plc, and Merck & Co.etc. The market has high level of competition and remains the same during the forecasted period with constant pressure on players to launch new products.
Scope of the Report
1. Global contraceptive market by products 2012 - 2022
1.1. Contraceptive Drugs
1.1.1. Contraceptive Pills
1.1.2. Topical
1.1.3. Injectable
1.2. Contraceptive Devices
1.2.1. Male Condoms
1.2.2. Female Condoms
1.2.3. Vaginal Implants
1.2.4. Subdermal Implants
1.2.5. Diaphragms
1.2.6. Sponges
1.2.7. IUDs
1.3. Copper IUD
1.4. Hormonal IUD
2. Global contraceptiveindustry, regional outlook 2012-2022 ($ BILLION)
2.1. North America
2.2. Europe
2.3. Asia Pacific
2.4. Middle East & Africa
2.5. Central & South America
3. Competitive Landscape
3.1. Actavis, Inc.
3.2. Bayer AG
3.3. Church & Dwight Co., Inc.c
3.4. Cooper Surgical, Inc.
3.5. Mayer Laboratories, Inc.
3.6. Merck & Co., Inc.
3.7. Pfizer, Inc
3.8. Reckitt Benckiser plc
3.9. Teva Pharmaceutical Industries Ltd.
3.10. The Female Health Company
3.11. Mankind
3.12. TTK-LIG
3.13. HLL Lifecare Limited
3.14. Pace Pharmaceuticals Inc
Request Sample: http://www.briskinsights.com/sample-request/89
About Us:
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions.
Contact Us:
Office 1094
109 Vernon House, Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Ph. No. +448081890034
Email: sales@briskinsights.com
Company: http://www.briskinsights.com